I have a broad experience in drug discovery within AstraZeneca having worked across several therapeutic areas since 1990. For 更多 than a decade, my focus has been on robotic microscopy and high-content biology, and I’ve established several laboratories based on these methods.

I joined Pharmaceutical Sciences in 2017 to bring biological insight to cellular delivery of novel chemical modalities, such as modified mRNA, using advanced nano-formulations.

I have established bioscience and high-throughput methods and improved our data science capabilities using automation and AI-assisted data acquisition and analysis.

My publication record includes more than 25 peer-reviewed articles, and I have worked in close collaboration with McMaster University in Canada and Lund University and the Karolinska Institute in Sweden.
 

There are various proteins involved in disease that conventional molecules can’t target. We refer to them as ‘undruggable’. By using new drug modalities which recognise the genetic sequence, and nanotechnology to deliver them directly to the site, we open whole new possibilities for treatment

Alan Sabirsh Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

英雄联盟哪里可以投注

CURRENT ROLE

英雄联盟赛事投注

2018

英雄联盟赛事投注

2014

英雄联盟赛事投注

2008

英雄联盟赛事投注

英雄联盟赛事投注

Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetesLOL赛事竞猜

Segerstolpe Å, Palasantza A, Eliasson P, Andersson EM,  Andersson EM, Andréasson AC, Sun X, Picelli S, Sanirsh A, Clausen M, Bjursell MK, Smith DM, Kasper M, Ämmälä C, Sandberg R. Cell Metabolism (2016), 24 (4), 593-607 Publication link.

The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. LOL赛事竞猜

Owman C, Garzino-Demo A, Cocchi F, Popovic C, Sabirsh A, Gallo RC. Proc Natl Acad Sci USA (1998), 95 (16), 9530-9534. Publication link.

Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responses. LOL赛事竞猜

Wan M, Sabirsh A, Wetterholm A, Agerberth B, Haeggstrom JZ. FASEB J (2007), 21 (11), 2897-2905. Publication link.

Long-term chronic toxicity testing using human pluripotent stem cell–derived hepatocytes.LOL赛事竞猜

Holmgren G, Sjögren AK, Barragan I, Sabirsh A, Sartipy P, Synnergren J, Björquist P, Ingelman-Sundberg M, Andersson TB, Edsbagge J. Drug Metabolism and Disposition (2014),  42 (9), 1401-1406. Publication link.

First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms.LOL赛事竞猜

Borgegard T, Juréus A, Olsson F, Rosqvist S,  Sabirsh A, Rotticci D, Paulsen K, Klintenberg R, Yan H, Waldman M, Stromberg K, Nord J, Johansson J, Regner A, Parpal S, Malinowsky D, Radesater C, Li T, Singh R, Eriksson H, Lunkvist J. Journal of Biological Chemistry (2012), 287 (15), 11810-11819. Publication link.

Role of B cell–activating factor (BAFF) in chronic obstructive pulmonary disease.LOL赛事竞猜

Seys LJM, Verhamme FM, Schinwald A, Hammad H, Cunoosamy DM, Bantsimba-Malanda C, Sabirsh A, McCall E, Flavell L, Herbst R, Provoost S, Lambrecht BN, Joos GF, Bruselle GG, Bracke KR. AJRCCM (2015), 192 (6), 706-718. Publication link.

Leukotriene B4 is the functional ligand binding to and activating the cloned chemoattractant receptor, CMKRL1. LOL赛事竞猜

Owman C, Sabirsh A, Boketoft Å, Olde B. Biochemical and biophysical research communications (1997), 240 (1), 162-166. Publication link.

Pro‐and anti‐inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes. Pettersson et al.LOL赛事竞猜

Journal of Leukocyte Biology (2005), 77 (6),1018-1025. Publication link.

First-generation monoclonal antibodies identifying the human leukotriene B4 receptor-1 Pettersson et al.LOL赛事竞猜

Biochemical and biophysical research communications (2000), 279 (2), 520-525. Publication link.

Residues from Transmembrane Helices 3 and 5 Participate in Leukotriene B4 Binding to BLT1.LOL赛事竞猜

Sabirsh A, Bywater RP, Bristulf J, Owmn C, Haeggström JZ. Biochemistry (2006), 45 (18), 5733-5744. Publication link.